New hope for breast cancer patients as life-extending drug now on NHS in England
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"Enhertu can be life-changing, and this recommendation means NHS patients will finally be able to benefit from it."
— Yvette Cooper , Politician
"Today we can finally say we did it. However, we can't celebrate this momentous decision without remembering the devastating cost of this delay."
— Claire Rowney , Executive
"I really can't believe it. I'm so relieved, I'm overjoyed."
— Kate Wills , Other
"I'm not ready to die yet. I want to stay alive, I want to keep living."
— Jeannie Ambrose , Other
Key People
Claire Rowney is the chief executive of the charity Breast Cancer Now.
Jeannie Ambrose was a breast cancer patient who passed away after campaigning for treatment access.
Kate Wills is a breast cancer patient who expressed her emotions about accessing Enhertu.
Yvette Cooper is a British Labour Party politician who has served in various ministerial roles.
Locations
All Coverage
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.
Similar Stories
Related coverage based on topic and tags
Cancer patient told she will get drug which could make her life longer
Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
September 17, 2026 at 05:28 AMAndy Burnham urged to set dementia waiting-time target
An 18‑week referral‑to‑treatment target has been backed by England's former national cancer director.
September 17, 2026 at 07:13 PMHow a rapid new test is helping brain tumour patients
A rapid new test for brain tumours that the NHS has started using can slash the time it takes for an accurate diagnosis from up to eight weeks to two hours.
September 25, 2026 at 06:50 AMUS FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMFrom weeks to hours - the rapid new test transforming brain tumour diagnosis
The test means patients can start treatment sooner and are spared weeks of uncertainty.
September 24, 2026 at 11:44 PMBlood tests find high level of cancer-causing forever chemical in residents near factory
People living near a major chemical factory in Lancashire are told they could be at risk of serious health conditions.
September 23, 2026 at 09:01 PM